Stock RHO5 ROCHE HOLDING AG
Add to a list
To use this feature you must be a member
Log inSign up

Company Roche Holding AG Deutsche Boerse AG

Equities

RHO5

CH0012032048

Pharmaceuticals

Delayed Deutsche Boerse AG
Other stock markets
 11:41:42 2019-06-28 am EDT 		5-day change 1st Jan Change
245.6 EUR -0.14% Intraday chart for Roche Holding AG -.--% -.--%
01:41pm ROCHE HOLDINGS AG : Barclays remains Neutral ZD
12:46pm ROCHE HOLDINGS AG : UBS reaffirms its Neutral rating ZD

Business Summary

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Number of employees: 103,605

Sales per Business

CHF in Million2022Weight2023Weight Delta
Pharmaceuticals
76.6 %
48,628 73.2 % 46,279 76.6 % -4.83%
Diagnostics
23.4 %
17,798 26.8 % 14,162 23.4 % -20.43%

Sales per region

CHF in Million2022Weight2023Weight Delta
United States
46.9 %
29,313 44.1 % 28,352 46.9 % -3.28%
Rest of Europe
16.1 %
10,328 15.5 % 9,703 16.1 % -6.05%
Rest of Asia
14.7 %
9,852 14.8 % 8,890 14.7 % -9.76%
Japan
7.4 %
6,452 9.7 % 4,464 7.4 % -30.81%
Latin America
4.9 %
2,870 4.3 % 2,971 4.9 % +3.52%
Germany
4.8 %
3,318 5.0 % 2,893 4.8 % -12.81%
Africa, Australia and Oceania
2.0 %
1,520 2.3 % 1,212 2.0 % -20.26%
Switzerland
1.8 %
1,671 2.5 % 1,118 1.8 % -33.09%
Rest of North America
1.4 %
1,102 1.7 % 838 1.4 % -23.96%

Managers

Managers TitleAgeSince
Thomas Schinecker CEO
 Chief Executive Officer 49 02-12-31
Severin Schwan CHM
 Chairman 57 07-12-31
Alan Hippe DFI
 Director of Finance/CFO 57 11-03-31
Pascale Schmidt CMP
 Compliance Officer 51 19-12-31
Levi Garraway CTO
 Chief Tech/Sci/R&D Officer - -
Bruno Eschli IRC
 Investor Relations Contact - -
Silke Hörnstein PRN
 Corporate Officer/Principal 49 14-12-31
Annette Luther SEC
 Corporate Secretary 54 20-03-31
Claudia Boeckstiegel LAW
 General Counsel 60 20-03-31
Cristina A. Wilbur HRO
 Human Resources Officer 57 -

Members of the board

Members of the board TitleAgeSince
Bernard Poussot BRD
 Director/Board Member 72 15-03-02
Ulf Mark Schneider BRD
 Director/Board Member 59 -
André S. Hoffmann BRD
 Director/Board Member 65 95-12-31
Patrick Frost BRD
 Director/Board Member 56 20-03-16
Hans Clevers PRN
 Corporate Officer/Principal 67 19-03-04
Severin Schwan CHM
 Chairman 57 07-12-31
Anita Hauser BRD
 Director/Board Member 55 17-03-13
Claudia Dyckerhoff BRD
 Director/Board Member 58 16-02-29
Jemilah Mahmood BRD
 Director/Board Member - -
Akiko Iwasaki BRD
 Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 106,691,000 28,989,189 ( 27.17 %) 0 88.91 %
Stock B 1 702,562,700 690,549,764 ( 98.29 %) 12,011,755 ( 1.710 %)

Shareholders

NameEquities%Valuation
ROCHE HOLDING AG
1.434 %
10,073,029 1.434 % 2 569 M €
MFS International (UK) Ltd.
0.5987 %
4,206,054 0.5987 % 1 073 M €
Swedbank Robur Fonder AB
0.3107 %
2,182,825 0.3107 % 557 M €
March Asset Management SGIIC SAU
0.2754 %
1,934,990 0.2754 % 493 M €
Universal-Investment-Gesellschaft mbH (Invt Mgmt)
0.2340 %
1,644,320 0.2340 % 419 M €
MFS International Singapore Pte. Ltd.
0.2219 %
1,558,649 0.2219 % 397 M €
State Street Global Advisors Ltd.
0.2152 %
1,511,620 0.2152 % 385 M €
CapitalatWork SA
0.1965 %
1,380,872 0.1965 % 352 M €
Swisscanto Fondsleitung AG
0.1907 %
1,339,459 0.1907 % 342 M €
Nordea Investment Management AB
0.1879 %
1,320,423 0.1879 % 337 M €
NameEquities%Valuation
MFS Investment Management Canada Ltd.
0.0493 %
2,768,432 0.0493 % 88 M €
Saratoga Research & Investment Management
0.0437 %
2,458,918 0.0437 % 78 M €
Pacer Advisors, Inc.
0.0196 %
1,099,659 0.0196 % 35 M €
NLG Capital, Inc.
0.0129 %
724,880 0.0129 % 23 M €
Van Kampen Asset Management
0.009381 %
527,280 0.009381 % 17 M €
Financial Gravity Asset Management, Inc.
0.009207 %
517,463 0.009207 % 17 M €
MFS International (UK) Ltd.
0.008446 %
474,717 0.008446 % 15 M €
Boston Common Asset Management LLC
0.008147 %
457,875 0.008147 % 15 M €
Truffle Asset Management (Pty) Ltd.
0.004877 %
274,100 0.004877 % 9 M €
Old National Bank (Investment Management)
0.004574 %
257,096 0.004574 % 8 M €
NameEquities%Valuation
Hoffmann Family
64.97 %
69,318,000 64.97 % 18 701 M €
Maja Oeri
7.584 %
8,091,900 7.584 % 2 183 M €
Severin Schwan
0.2294 %
244,786 0.2294 % 66 M €
Rothschild & Co. Bank AG
0.1893 %
202,000 0.1893 % 54 M €
Ignis Investment Services Ltd.
0.1660 %
177,114 0.1660 % 48 M €
Goldman Sachs Advisors BV
0.1574 %
167,973 0.1574 % 45 M €
Pareto Asset Management AS
0.1492 %
159,150 0.1492 % 43 M €
zCapital AG
0.1087 %
116,000 0.1087 % 31 M €
ODDO BHF Trust GmbH
0.0964 %
102,850 0.0964 % 28 M €
Aberdeen Standard Investments (Japan) Ltd.
0.0540 %
57,600 0.0540 % 16 M €

Holdings

NameEquities%Valuation
CHUGAI PHARMACEUTICAL CO., LTD
59.89%
 1,005,670,000 59.89% 38,367,557,531 $
ROCHE HOLDING AG
1.43%
 10,073,029 1.43% 2,568,862,838 $
ENTRADA THERAPEUTICS, INC.
8.17%
 2,744,120 8.17% 38,884,180 $
JASPER THERAPEUTICS, INC.
3.02%
 454,961 3.02% 13,357,655 $
ALIGOS THERAPEUTICS, INC.
15.19%
 11,025,941 15.19% 10,805,422 $
ELOXX PHARMACEUTICALS, INC.
0.06%
 1,893 0.06% 1,893 $

Company contact information

Roche Holding AG

Grenzacherstrasse 124

4058, Basel

+41 61 688 11 11

http://www.roche.com
address Roche Holding AG(RHO5)

Group companies

NameCategory and Sector
Sapac Corp. Ltd.
Roche Pharmholding BV
Logo Roche Pharmholding BV

Roche Pharmholding BV

Medical DistributorsDistribution Services

Part of Roche Holding AG, Roche Pharmholding BV is a Dutch company that manufactures and distributes pharmaceutical and vitamin products. The private company is based in Woerden, Netherlands.

Medical Distributors
Roche Finance Europe BV
Finance/Rental/Leasing
Roche Catalyst Investments Ltd.
Roche Financial Investments Ltd.
Roche Intertrade Ltd.
Roche Diagnostics India Pvt Ltd.
Logo Roche Diagnostics India Pvt Ltd.

Roche Diagnostics India Pvt Ltd.

Medical SpecialtiesHealth Technology

Founded in 1988, Roche Diagnostics India Pvt Ltd. is a subsidiary of Roche Holding AG. The private company is based in Mumbai, India. The Indian company manufactures diagnostic systems and devices for patients, clinicians, and researchers.

Medical Specialties
Viewics India Pvt Ltd.
Roche Financial Management Ltd.

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
229.7 CHF
Average target price
281.1 CHF
Spread / Average Target
+22.36%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.77% 672B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.00% 570B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.04% 360B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.69% 321B
ABBVIE INC. Stock AbbVie Inc.
+8.45% 300B
ASTRAZENECA PLC Stock AstraZeneca PLC
+6.74% 217B
NOVARTIS AG Stock Novartis AG
+5.08% 199B
PFIZER, INC. Stock Pfizer, Inc.
-9.28% 149B
AMGEN INC. Stock Amgen Inc.
-5.00% 147B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. ROG Stock
  4. RHO5 Stock
  5. Company Roche Holding AG